The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Anti‐cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF‐κB
Abstract
BACKGROUND: Bee venom has been used as a traditional medicine to treat arthritis, rheumatism, back pain, cancerous tumors, and skin diseases. However, the effects of bee venom on the prostate cancer and their action mechanisms have not been reported yet. METHODS T: o determine the effect of bee venom and its major component, melittin on the prostate cancer cells, apoptosis is analyzed by tunnel assay and apoptotic gene expression. For xenograft studies, bee venom was administrated intraperitoneally twice per week for 4 weeks, and the tumor growth was measured and the tumor were analyzed by immunohistochemistry. To investigate whether bee venom and melittin can inactivate nuclear factor kappa B (NF‐κB), we assessed NF‐κB activity in vitro and in vivo. RESULTS AND CONCLUSIONS: Bee venom (1–10 µg/ml) and melittin (0.5–2.5 µg/ml) inhibited cancer cell growth through induction of apoptotic cell death in LNCaP, DU145, and PC‐3 human prostate cancer cells. These effects were mediated by the suppression of constitutively activated NF‐κB. Bee venom and melittin decreased anti‐apoptotic proteins but induced pro‐apoptotic proteins. However, pan caspase inhibitor abolished bee venom and melittin‐induced apoptotic cell death and NF‐κB inactivation. Bee venom (3–6 mg/kg) administration to nude mice implanted with PC‐3 cells resulted in inhibition of tumor growth and activity of NF‐κB accompanied with apoptotic cell death. Therefore, these results indicated that bee venom and melittin could inhibit prostate cancer in in vitro and in vivo, and these effects may be related to NF‐κB/caspase signal mediated induction of apoptotic cell death. Prostate 71:801–812, 2011. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
Malik, A., Afaq, F., Sarfaraz, S., Adhami, V. M., Syed, D. N., & Mukhtar, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505870102 · Cited by 401
Secondary Hormonal Therapy for Advanced Prostate Cancer
Lam, J. S., Leppert, J. T., Vemulapalli, S. N., Shvarts, O., & Belldegrun, A. S. (2006) · Journal of Urology · doi:10.1016/s0022-5347(05)00034-0 · Cited by 153
Cited by
Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy
Rady, I., Siddiqui, I. A., Rady, M., & Mukhtar, H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.010 · Cited by 387
Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests
Wehbe, R., Frangieh, J., Rima, M., El Obeid, D., Sabatier, J.-M., & Fajloun, Z. (2019) · Molecules · doi:10.3390/molecules24162997 · Cited by 372
Al-Asmari, A., Anvarbatcha, R., Al-Shahrani, M., & Islam, M. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s115055 · Cited by 41
Metadata
- Authors
- Park, M. H., Choi, M. S., Kwak, D. H., Oh, K., Yoon, D. Y., Han, S. B., Song, H. S., Song, M. J., & Hong, J. T.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2010-11-17
- Volume
- 71
- Issue
- 8
- Pages
- 801-812
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2091037838
- Cited by
- 175
- References
- 3
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti‐cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF‐κB. https://app.cochat.ai/papers/10.1002/pros.21296
- The paper
- Park, M. H., Choi, M. S., Kwak, D. H., Oh, K., Yoon, D. Y., Han, S. B., Song, H. S., Song, M. J., & Hong, J. T. (2011). Anti‐cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF‐κB. The Prostate. https://doi.org/10.1002/pros.21296
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.